Plain-English translation of NCT06975787 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing two experimental medications called and to see if they can help treat lupus nephritis—a condition where lupus damages the kidneys. The study will look at how safe these medications are, what side effects they might cause, and how well the body tolerates them over time.
Lupus nephritis is a serious complication of lupus that can lead to kidney failure. Some patients don't respond well to standard treatments, so researchers are testing this medication to offer a new option for people whose disease keeps coming back or doesn't improve with current therapies.
You likely qualify if…
You likely don't qualify if…
You would receive the medication for a short period and then be followed closely by the research team to monitor how your body responds. The study will involve blood tests to check drug levels in your blood, assess any side effects, and see whether your body develops antibodies against the medication. You'll have regular visits with the research team for long-term follow-up to ensure your safety.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
United States
Germany
South Korea